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ABSTRACT
Background: The prevalence of Helicobacter pylori (H. pylori) infection in the world is quite high, espe-
cially in developing countries.  Usually the patient shows no specific symptoms and chronic gastritis there-
fore becomes chronically infected. The complication of the infection is the development of peptic ulcer, which
is a predisposing factor for gastric carcinoma. Early diagnosis is an important step to avoid these complica-
tions by providing immediate accurate therapy.
Methods: In this study, the CLO, MIU (Motility Indole Urease) tests and culture were conducted on 131
biopsy samples of the stomach antrum mucous tissue taken from chronic dyspepsia patients from several
hospitals in Jakarta.  In the CLO test, biopsy tissue was put in a small well agar to be incubated at room
temperature. In the MIU test the biopsy tissue sample was submerged in the small MIU tube agar with a depth
of approximately 2/3 rds from the surface, and then incubated at room temperature. Another piece of biopsy
tissue was cultured micro-aerophylically.  The CLO and MIU tests are considered positive if the color changes
from yellow to red, and are considered negative if there is no color change within 24 hours.
Results: Compared to culture, the CLO test demonstrated 38% sensitivity, 96% specificity, 94% positive
predictive value and 52% negative predictive value, whereas the results of the MIU test against culture
method showed 76% sensitivity, 89% specificity, 88% positive predictive value, and 78%  negative predictive
value.
Conclusion: The MIU test that showed high sensitivity and specificity, and thus could be further devel-
oped as an alternative diagnostic method for H. pylori infection.
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INTRODUCTION
Helicobacter pylori (H.pylori) is a microorganism
that often causes chronic bacterial infection in humans
and infects almost half of the world population. The habitat
of this bacteria is the human stomach, and therefore the
H. pylori infection is the main cause of active chronic
gastritis, gastric ulcer, and duodenal ulcer1,2,3,4.. Recently,
it has been proven to be the highest risk factor in stom-
ach cancer5,6,7,8.
The prevalence of H. pylori infection is quite high, in
developed countries as well as in developing countries,
such as Indonesia. The prevalence of H. pylori infec-
tion in developed countries is around 40-50%, whereas
in developing countries, where the infection occurs from
a very young age, the prevalence can reach up to
80%9,10. Several complications that can be caused by
this infection are: duodenal ulcer, gastric ulcer and gas-
tric carcinoma. The negative impact of this infection on
the individual and the community is a deterioration of the
quality of human resources and high cost of therapy. For
this reason, there is a need for a simple detection method
to identify H. pylori infection, which can provide high
specificity and sensitivity at low cost.
Generally, people who suffer from H. pylori infec-
tion do not show any specific symptoms. They are some-
times asymptomatic, leading to a chronic disease. There-
fore, laboratory procedures are essential to establish the
diagnosis of H. pylori infection. A widely used method
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is the urease test, which is performed using the
Campylobacter-Like Organism (CLO) kit. However, it
often results in a false negative, and is quite expensive.
Another method is by testing the urease enzyme of the
H. pylori, otherwise known as the Motility Indol Ure-
ase (MIU) technique, which was also used in this study.
The aim of this study is to assess the sensitivity, speci-
ficity, positive and negative prediction values of the MIU
and CLO tests against the culture method as the gold
standard.
MATERIAL AND METHODS
Biopsy samples of the gastric antrum were taken
from 131 patients with chronic dispepsia who visited the
endoscopy department and informedly consented.
Samples were collected from several private and gen-
eral hospitals in Jakarta. Four antrum biopsy tissues of
different locations were taken from each patient: 2 tis-
sues for the CLO test and another 2 for culture and the
MIU test.
Isolation and Identification
Each antrum biopsy tissue were aseptically cut into 4
pieces. Each piece of tissue was grown in Thioglikolate
Broth, MIU, Brucella Blood Agar and DENT Blood
Agar. Cultures were incubated micro-aerophylically at
37oC for 3-7 days in an anaerobic jar with a
“Campylobacter” BR 56 (Oxoid) kit containing a BR 46
catalyst.
Small translucent colonies grown on Brucella Blood
Agar were presumed as the H. pylori colonies. On the
DENT Blood Agar, the color of the colony was gray.
Identification was confirmed through microscopic ob-
servation using Gram stain and biochemical tests. Iden-
tification of a curved or spiral negative Gram bacteria
under the microscope and positive catalase, oxidase and
urease biochemical tests confirmed that the bacteria were
H. pylori.
In sulfur glycolate culture, H. pylori are seen as spi-
ral or bold line tail-like shapes coming out of the the bi-
opsy tissue. Identification was performed using the mi-
croscope and reculturization of the tissue on a Brucella
blood agar. In a semisolid MIU culture, a color change
from yellow to red accompanied by positive motility were
presumably caused by H. pylori. Further identification
was conducted using a microscopic and other biochemi-
cal tests.
RESULTS
Distribution of H. pylori Based on Clinical Report
Out of 131 dyspepsia patients, 107 cases were non-
ulcer dyspepsia, 61 of which positive for H. pylori from
the culture, 18 cases were gastric ulcer, 17 of which
were positive for H. pylori from the culture; 6 cases
were duodenal ulcer, all of which were positive for H.
pylori from the culture (Table 1).
Comparison Between CLO Test and Culture
Compared to the tissue culture, the CLO test dem-
onstrated 38% sensitivity, 96% specificity, 94% positive
prediction value and 52% negative prediction value.
Marginal Chi-square was 41.405, with a df of 1, and P <
0.05. The result can be found in Table 2.
MIU Test Result Against Culture
Comparison of the MIU test result against culture as
“Gold Standard” provided 76% sensitivity, 89% speci-
ficity, 88% positive prediction value and 78% negative
prediction value (Table 3). Marginal Chi-square was
41.405, with a df of 1, and P < 0.05.
 
Table 1. Distribution of  H. pylori  based on clinical 
report 
Clinical Report H. pylori 
Positive       
H. pylori 
Negative    
Total 
Non-ulcer 
dyspepsia             
61  (57%)         46 (43%)    107 
(100%) 
Gastric ulcer        17   (94%)        1 (  6%)      18 (100%) 
Duodenal ulcer 6 (100%)          0 (  0%)      6 (100%) 
 




  Total 
+ 29 2 31 CLO 
- 48 52 100 
Total 77 54 131 
P < 0,05 
Sensitivity: 38 %    Positive prediction value: 94 % 
Specificity: 96 %    Negative prediction value: 52 % 




  Total 
+ 51 7 58 MIU 
- 16 57 73 
Total 67 64 131 
p > 0,05 
 
Sensitivity: 76 %     Positive prediction value:  88 % 
Specificity: 89 %     Negative prediction value: 78 % 
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DISCUSSION
CLO Test Result Compared to Culture
Compared to culture, the sensitivity of the CLO test
result was a very low 38%, although the specificity was
a relatively high 96%. The low sensitivity of the CLO
test could be due to an inadequate number of bacteria in
the biopsy tissue. Thus, the urease enzyme yield was
insufficient to react with urea within a short time. The
urease enzyme requires a longer time to be able to react
with the urea, and therefore evaluation within 24 hours
using the CLO test often results in a false negative.11
Another possible reason may be the effect of chemical
or long term medication, which reduce urease activity in
H. pylori, inhibiting breakdown of urea into ammonia
and bicarbonate.12,13 A medicine that can influence ure-
ase activity and motility of H. pylori is the “proton pump
inhibitor”, which is usually used to suppress the growth
of H. pylori.14 According to Gowan, Omeprazol, a medi-
cine of “Proton pump inhibitor” group, selectively works
to inhibit urease activity.15,16
Other possible cause of the low sensitivity of the CLO
test was the patient’s mistake of taking inappropriate
doses of antimicrobial drug, causing suppression, but not
eradication of bacterial growth. Thus, the drug only re-
duces the number of bacteria, but allows it to move to
other parts of the stomach, such as the corpus area. It
seems therefore that collection of biopsy tissue sample
from the antrum may only result in a false negative.17
Comparation of the MIU Test Result and Culture
Urease test using MIU culture within 24 hours re-
sulted in 76% sensitivity, 89% specificity, 88% positive
prediction value and 78% negative prediction value.
Compared to the CLO test, the result of MIU showed
higher sensitivity and specificity. This might be due to
the nutrient contained in the MIU medium and the growth
environment, such as the pH and micro-aerophylic con-
dition that were more suitable to promote H. pylori
growth. Several previous studies in Western countries
showed that sensitivity and specificity of the urease rapid
test could be influenced by several factors, such as
whether the incision area of the biopsy tissue was at the
antrum, fundus, and mucosal corpus of the stomach. This
is because the number of bacteria found at the antrum,
fundus, and corpus could create a positive urease test.
Furthermore, urea concentration, nutrient availability and
pH of the medium used for the test would also influence
the sensitivity and specificity of the urea test17,18,19 .
An advantage of the MIU test is that it can show
bacteria motility for a relatively low cost.
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